Next Stage: Trial Spark

TrialSpark is a technology-driven pharma company that runs end-to-end clinical trials, focused on bringing new treatments to patients faster and more efficiently. TrialSpark has built a technology platform that optimizes all aspects of a clinical trial, enabling more efficient trial design, faster trial completion, and higher quality trial data capture. With these unique trial capabilities and an investment mandate focused on clinical-stage assets, we are looking to in-license and co-develop drug programs through in-house development, joint ventures, and NewCos. Early in their development, the company participated in AlphaLab, and they are coming back to Pittsburgh to share their story and spread the word about their product.

TrialSpark will be speaking at BioBreakfast sponsored by Innovation Works.